Cargando…

Centronuclear Myopathy Caused by Defective Membrane Remodelling of Dynamin 2 and BIN1 Variants

Centronuclear myopathy (CNM) is a congenital myopathy characterised by centralised nuclei in skeletal myofibers. T-tubules, sarcolemmal invaginations required for excitation-contraction coupling, are disorganised in the skeletal muscles of CNM patients. Previous studies showed that various endocytic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujise, Kenshiro, Noguchi, Satoru, Takeda, Tetsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181712/ https://www.ncbi.nlm.nih.gov/pubmed/35682949 http://dx.doi.org/10.3390/ijms23116274

Ejemplares similares

Mutant BIN1-Dynamin 2 complexes dysregulate membrane remodeling in the pathogenesis of centronuclear myopathy
por: Fujise, Kenshiro, et al.
Publicado: (2020)

Structural insights into the centronuclear myopathy-associated functions of BIN1 and dynamin 2
por: Hohendahl, Annika, et al.
Publicado: (2016)

Mutations in BIN1 Associated with Centronuclear Myopathy Disrupt Membrane Remodeling by Affecting Protein Density and Oligomerization
por: Wu, Tingting, et al.
Publicado: (2014)

MTM1 overexpression prevents and reverts BIN1-related centronuclear myopathy
por: Giraud, Quentin, et al.
Publicado: (2023)

Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model
por: Fongy, Anaïs, et al.
Publicado: (2019)

Allele‐specific silencing therapy for Dynamin 2‐related dominant centronuclear myopathy
por: Trochet, Delphine, et al.
Publicado: (2017)

Physiological impact and disease reversion for the severe form of centronuclear myopathy linked to dynamin
por: Muñoz, Xènia Massana, et al.
Publicado: (2020)

Novel SPEG variant cause centronuclear myopathy in China
por: Tang, Jia, et al.
Publicado: (2019)

Calcium homeostasis alterations in a mouse model of the Dynamin 2-related centronuclear myopathy
por: Fraysse, Bodvaël, et al.
Publicado: (2016)

Differential impact of ubiquitous and muscle dynamin 2 isoforms in muscle physiology and centronuclear myopathy
por: Gómez-Oca, Raquel, et al.
Publicado: (2022)

Centronuclear (myotubular) myopathy
por: Jungbluth, Heinz, et al.
Publicado: (2008)

BIN1 modulation in vivo rescues dynamin-related myopathy
por: Lionello, Valentina Maria, et al.
Publicado: (2022)

Dynamin-2 mutations linked to Centronuclear Myopathy impair actin-dependent trafficking in muscle cells
por: González-Jamett, Arlek M., et al.
Publicado: (2017)

Altered Splicing of the BIN1 Muscle-Specific Exon in Humans and Dogs with Highly Progressive Centronuclear Myopathy
por: Böhm, Johann, et al.
Publicado: (2013)

Pathogenic Mechanisms in Centronuclear Myopathies
por: Jungbluth, Heinz, et al.
Publicado: (2014)

Correction: Altered Splicing of the BIN1 Muscle-Specific Exon in Humans and Dogs with Highly Progressive Centronuclear Myopathy
por: Böhm, Johann, et al.
Publicado: (2013)

Mild Functional Differences of Dynamin 2 Mutations Associated to Centronuclear Myopathy and Charcot-Marie-Tooth Peripheral Neuropathy
por: Koutsopoulos, Olga S., et al.
Publicado: (2011)

Centronuclear myopathy related to dynamin 2 mutations: Clinical, morphological, muscle imaging and genetic features of an Italian cohort
por: Catteruccia, Michela, et al.
Publicado: (2013)

A case of de novo dynamin 2 (DNM2)-related centronuclear myopathy with electrical but not clinical myotonia
por: Huang, Xiao, et al.
Publicado: (2020)

Case report of intrafamilial variability in autosomal recessive centronuclear myopathy associated to a novel BIN1 stop mutation
por: Böhm, Johann, et al.
Publicado: (2010)

Benefits of therapy by dynamin-2-mutant-specific silencing are maintained with time in a mouse model of dominant centronuclear myopathy
por: Trochet, Delphine, et al.
Publicado: (2022)

Gain-of-Function Dynamin-2 Mutations Linked to Centronuclear Myopathy Impair Ca(2+)-Induced Exocytosis in Human Myoblasts
por: Bayonés, Lucas, et al.
Publicado: (2022)

Phospholamban overexpression in mice causes a centronuclear myopathy-like phenotype
por: Fajardo, Val A., et al.
Publicado: (2015)

Autosomal Dominant Centronuclear Myopathy with Unique Clinical Presentations
por: Lee, Jee-Young, et al.
Publicado: (2007)

Suspected Congenital Centronuclear Myopathy in an Arabian‐cross Foal
por: Polle, F., et al.
Publicado: (2014)

Clinical, genetic, and histological features of centronuclear myopathy in the Netherlands
por: Reumers, Stacha F. I., et al.
Publicado: (2021)

Phenotypic Spectrum of DNM2-Related Centronuclear Myopathy
por: Hayes, Leslie Hotchkiss, et al.
Publicado: (2022)

N-WASP is required for Amphiphysin-2/BIN1-dependent nuclear positioning and triad organization in skeletal muscle and is involved in the pathophysiology of centronuclear myopathy
por: Falcone, Sestina, et al.
Publicado: (2014)

Centronuclear myopathies under attack: A plethora of therapeutic targets
por: Tasfaout, Hichem, et al.
Publicado: (2018)

A Possible Case of Centronuclear Myopathy: A Case Report
por: Castillo-Ferrán, Narjara, et al.
Publicado: (2023)

DNM2 mutations in a cohort of sporadic patients with centronuclear myopathy
por: Abath, Osorio, et al.
Publicado: (2015)

Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances
por: Gómez-Oca, Raquel, et al.
Publicado: (2021)

Characterization of a novel zebrafish model of SPEG-related centronuclear myopathy
por: Espinosa, Karla G., et al.
Publicado: (2022)

Clinical and Pathological Features of Korean Patients with DNM2-Related Centronuclear Myopathy
por: Park, Young-Eun, et al.
Publicado: (2014)

Phosphatase-Dead Myotubularin Ameliorates X-Linked Centronuclear Myopathy Phenotypes in Mice
por: Amoasii, Leonela, et al.
Publicado: (2012)

A novel SPEG mutation causes non-compaction cardiomyopathy and neuropathy in a floppy infant with centronuclear myopathy
por: Wang, Haicui, et al.
Publicado: (2018)

A rare case of centronuclear myopathy with DNM2 mutation: genotype–phenotype correlation
por: Aghbolaghi, Amir Ghorbani, et al.
Publicado: (2017)

Hierarchical Bayesian modelling of disease progression to inform clinical trial design in centronuclear myopathy
por: Fouarge, Eve, et al.
Publicado: (2021)

A dog model for centronuclear myopathy carrying the most common DNM2 mutation
por: Böhm, Johann, et al.
Publicado: (2022)

Centronuclear myopathy due to a de novo nonsense variant and a maternally inherited splice‐site variant in TTN: A case report
por: Huang, Sheng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_umbgdtg1rm126k5bs3mpgr12id